Over 90% of drugs fail during clinical development, costing billions and leaving patients without life-saving treatments. Why does the pharmaceutical industry face such a high drug development failure rate, and how can artificial intelligence change the story?

In this episode, Vitalay Fomin, CEO and co-founder of Numenos AI, reveals how his team is rethinking clinical trials, biomarker discovery, and drug development with advanced AI technologies designed to predict patient response, reduce late-stage trial failures, and accelerate medicines to market.

Vitalay shares:

Why traditional clinical trial design contributes to such high failure rates
How AI can predict drug response across different cancers and diseases
The importance of moving beyond binary “responder / non-responder” models
How Numenos AI uses cross-disease data to uncover hidden treatment insights
The role of AI in drug toxicity prediction and improving patient safety
Why the pharma industry needs a mindset shift toward embracing novel technologies
The potential of AI to reduce Phase 2 and Phase 3 clinical trial failures
A case study: how Numenos AI predicted the failure of a major immunotherapy target (TIGIT)

This episode is essential listening for:

Pharma executives and biotech leaders looking to cut R&D costs
Clinical trial designers and data scientists in life sciences
Healthcare innovators and AI in medicine researchers
Investors in biotech, healthtech, and AI-driven drug discovery
Patients and advocates who want to understand how AI can accelerate safe, effective treatments

About the Podcast

AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future.

This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights.

AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.

As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.

This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.

Dr. Andree Bates LinkedIn | Facebook | Twitter

Why Clinical Drug Development Keeps Failing

AI For Pharma Growth